4.6 Article

Causal integration of multi-omics data with prior knowledge to generate mechanistic hypotheses

Journal

MOLECULAR SYSTEMS BIOLOGY
Volume 17, Issue 1, Pages -

Publisher

WILEY
DOI: 10.15252/msb.20209730

Keywords

causal reasoning; kidney cancer; metabolism; multi-omics; signaling

Funding

  1. European Union [675585]
  2. German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung BMBF) MSCoreSys research initiative research core SMART-CARE [031L0212A]
  3. JRC - Bayer AG
  4. Medical Research Council [MC_UU_12022/6]
  5. Novo Nordisk Foundation [NNF14CC0001]
  6. Danish Council for Independent Research [8020-00100B]
  7. Lundbeck Foundation [R193-2015-243]
  8. German Research Foundation (DFG) [SFBTRR57, SFBTRR219, CRU344]
  9. European Research Council [ERC-StG 677448]
  10. State of North Rhine-Westphalia
  11. BMBF eMed Consortia Fibromap
  12. ERA-CVD Consortia MEND-AGE
  13. Else Kroener Fresenius Foundation (EKFS)
  14. Interdisciplinary Centre for Clinical Research (IZKF) within the faculty of Medicine at the RWTH Aachen University [O3-11]
  15. German Society of Internal Medicine (DGIM)
  16. ProjektDEAL
  17. MRC [MC_UU_12022/6] Funding Source: UKRI

Ask authors/readers for more resources

COSMOS is a method that integrates multiple omics datasets to provide mechanistic hypotheses for experimental observations through network-level causal reasoning and activity estimation. When applied to a ccRCC dataset, COSMOS successfully captures relevant crosstalks within and between different omics layers.
Multi-omics datasets can provide molecular insights beyond the sum of individual omics. Various tools have been recently developed to integrate such datasets, but there are limited strategies to systematically extract mechanistic hypotheses from them. Here, we present COSMOS (Causal Oriented Search of Multi-Omics Space), a method that integrates phosphoproteomics, transcriptomics, and metabolomics datasets. COSMOS combines extensive prior knowledge of signaling, metabolic, and gene regulatory networks with computational methods to estimate activities of transcription factors and kinases as well as network-level causal reasoning. COSMOS provides mechanistic hypotheses for experimental observations across multi-omics datasets. We applied COSMOS to a dataset comprising transcriptomics, phosphoproteomics, and metabolomics data from healthy and cancerous tissue from eleven clear cell renal cell carcinoma (ccRCC) patients. COSMOS was able to capture relevant crosstalks within and between multiple omics layers, such as known ccRCC drug targets. We expect that our freely available method will be broadly useful to extract mechanistic insights from multi-omics studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available